Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Transl Res. 2015 Jun 23;167(1):7–34. doi: 10.1016/j.trsl.2015.06.011

Table 2.

Preclinical Studies Demonstrating the Importance of HO-1 in Disease

Strain Model Phenotype Refs

Hmox1−/− Vascular Injury Increased intimal hyperplasia 29
Pulmonary Ischemia/Reperfusion Repression of fibrinolysis 30
Hypoxia Increased myocardial infarction, Right ventricular dilation 31

Hmox1TG (Cardiac) Ischemia/Reperfusion Protection from I/R injury 32
Reduction of cardiomyocyte apoptosis 33
Hmox1TG (Cardiac, Inducible) Cardiotoxicity (Cre-recombinase) Protection from cardiotoxicity 34

Hmox1TG (Pulmonary) Hypoxia-induced pulmonary hypertension Reduced symptoms of hypertension 35
Anti-inflammatory protection 36

Hmox1TG (Keratinocyte) Skin lesions Improved wound healing and vascularization 37